Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

AVADEL PHARMACEUTICALS PLC

(AVDL)
  Report
Delayed Nasdaq  -  04:00 2022-12-07 pm EST
8.680 USD   +3.95%
12/06European Equities Largely Flat After Opening Lower in Tuesday Trading
MT
12/05After Seesaw Opening, European Equities Little Changed in Monday Trading
MT
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Slip Pre-Bell Thursday

09/01/2022 | 09:10am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AVADEL PHARMACEUTICALS PLC 3.95% 8.68 Delayed Quote.8.29%
HERCULES CAPITAL, INC. 0.97% 13.56 Delayed Quote.-19.05%
PROVENTION BIO, INC. 2.24% 9.13 Delayed Quote.58.90%
WEREWOLF THERAPEUTICS, INC. -6.13% 1.53 Delayed Quote.-86.31%
All news about AVADEL PHARMACEUTICALS PLC
12/06European Equities Largely Flat After Opening Lower in Tuesday Trading
MT
12/05After Seesaw Opening, European Equities Little Changed in Monday Trading
MT
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
12/01Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
AQ
12/01European Equities Move Higher Thursday as EU Nears Cap on Russian Oil
MT
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/30Jefferies Upgrades Avadel Pharmaceuticals to Buy From Hold, Raises Price Target to $11 ..
MT
11/29Inflation Decline in Germany, Spain Helps Boost European Equities
MT
11/23Insider Buy: Avadel Pharmaceuticals
MT
11/22Avadel Pharmaceuticals to Present at Upcoming Investor Conferences
AQ
More news
Analyst Recommendations on AVADEL PHARMACEUTICALS PLC
More recommendations
Financials (USD)
Sales 2022 - - -
Net income 2022 -127 M - -
Net cash 2022 134 M - -
P/E ratio 2022 -4,22x
Yield 2022 -
Capitalization 516 M 516 M -
EV / Sales 2022 -
EV / Sales 2023 24,4x
Nbr of Employees 66
Free-Float 57,7%
Chart AVADEL PHARMACEUTICALS PLC
Duration : Period :
Avadel Pharmaceuticals plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AVADEL PHARMACEUTICALS PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Last Close Price 8,35 $
Average target price 12,25 $
Spread / Average Target 46,7%
EPS Revisions
Managers and Directors
Gregory J. Divis Chief Executive Officer & Director
Thomas S. McHugh Chief Financial Officer & Senior Vice President
Geoffrey Michael Glass Non-Executive Chairman
Jason Vaughn Senior Vice President-Technical Operations
Jennifer Gudeman Vice President-Medical & Clinical Affairs
Sector and Competitors
1st jan.Capi. (M$)
AVADEL PHARMACEUTICALS PLC8.29%516
JOHNSON & JOHNSON4.51%460 411
ELI LILLY AND COMPANY33.69%350 179
ABBVIE INC.20.92%289 437
NOVO NORDISK A/S21.77%285 921
PFIZER, INC.-14.09%279 038